
BGM is a commonly used medical abbreviation that typically refers to blood glucose monitoring. This process is crucial for individuals with diabetes to effectively manage their blood sugar levels. BGM can also refer to BioGenomics Medicine, an emerging field that combines medicine and genomics.
| Characteristics | Values |
|---|---|
| Full Form | Blood Glucose Monitoring |
| Used for | Determination of glucose mainly by diabetic patients |
| Use case | Used as a point-of-care test device |
| Use case example | Abbott's Freestyle Libre Flash Glucose Monitoring System |
Explore related products
What You'll Learn

Blood Glucose Monitoring
BGM commonly refers to Blood Glucose Monitoring, a crucial process for individuals with diabetes to manage their blood sugar levels effectively. Blood glucose monitoring helps identify patterns in the fluctuation of blood glucose (sugar) levels that occur in response to diet, exercise, medications, and pathological processes associated with blood glucose fluctuations, such as diabetes mellitus. Unusually high or low blood glucose levels can potentially lead to life-threatening conditions, both acute and chronic.
It is important not to share blood sugar monitoring equipment, especially lancets, with anyone else. Test strips can be damaged if exposed to moisture, humidity, or extreme temperatures, so it is important to store them in a closed container in a suitable environment.
Strategies to Excel as a Hospital Manager
You may want to see also
Explore related products

BioGenomics Medicine
BGM is a medical abbreviation with several meanings, one of which is BioGenomics Medicine. This field combines genomics and medicine, focusing on health and diabetes contexts.
Applications of BioGenomics Medicine
One of the critical applications of BGM is in diabetes management, as seen with Blood Glucose Monitoring (BGM) systems. These systems allow people with diabetes to monitor their blood sugar levels without the need for routine finger sticks, which are often painful and costly. This empowers patients and their physicians to make informed treatment decisions together.
Benefits of BioGenomics Medicine
BGM offers several advantages in healthcare:
- Personalized Medicine: By analyzing a person's genome, BGM can identify genetic variations that influence disease risk, response to medications, and treatment outcomes. This information can then be used to tailor preventative strategies and treatments to the individual, potentially improving efficacy and reducing adverse effects.
- Early Disease Detection: BGM can facilitate the development of genetic tests to identify individuals at risk for specific diseases before they exhibit any symptoms. This early detection provides a window of opportunity for preventative measures and early intervention, potentially improving long-term outcomes.
- Drug Development: A better understanding of genetic variations can accelerate drug development by identifying novel drug targets and streamlining the process of bringing new treatments to market.
- Nutrigenomics: BGM can also be applied to nutrition, helping individuals make dietary choices that optimize their health based on their genetic makeup.
Future of BioGenomics Medicine
With ongoing advancements in genetic research and technology, BGM is expected to play an increasingly significant role in healthcare. As our understanding of the genome expands, so too will the potential applications of BGM in disease prevention, diagnosis, and treatment. The field holds great promise for more precise and personalized medicine, ultimately improving patient outcomes and quality of life.
Medicare Hospital Stays: How Many Days Are Covered?
You may want to see also
Explore related products

BGM replacement indication
BGM stands for Blood Glucose Monitoring, a crucial process for individuals with diabetes to manage their blood sugar levels effectively. BGM replacement indication means that people with diabetes and their doctors can now make treatment decisions based on information from the FreeStyle Libre system, without the need for painful routine finger pricks.
Before December 2016, the CGM systems commercially available in the U.S. were approved by the U.S. Food and Drug Administration (FDA) for use only as adjunctive devices to information obtained from standard home blood glucose monitoring (BGM). This meant that a BGM measurement was required to confirm the CGM sensor glucose concentration before making an insulin dosing decision. However, with advancements in sensor technology, CGM systems have become increasingly accurate, and the FDA has since expanded the indications for some sensors to allow for the replacement of fingerstick blood glucose testing.
The REPLACE-BG study compared continuous glucose monitoring (CGM) with and without routine blood glucose monitoring (BGM) in adults with well-controlled type 1 diabetes. The study found that even when the FDA labeling limited CGM use to an adjunct-only tool, many CGM users were making insulin dosing decisions by CGM alone. Despite this, to date, no clinical trials have confirmed the safety and effectiveness of CGM used without BGM to make therapeutic decisions in people with type 1 diabetes.
BGM devices, such as the FreeStyle Libre system, provide a single glucose reading each time a finger is pricked. On the other hand, CGM devices provide continuous glucose readings 24/7 to a compatible smart device without the need for fingersticks. However, if glucose alerts and readings from a CGM device do not match symptoms or expectations, it is important to use a blood glucose meter to make diabetes treatment decisions.
In summary, BGM replacement indication refers to the use of alternative methods, such as CGM systems, to replace traditional BGM devices for blood glucose monitoring and treatment decisions in individuals with diabetes. While CGM systems offer continuous glucose readings and convenience, BGM devices provide a single, accurate reading that is crucial for confirming glucose levels and making informed treatment decisions when needed.
IHSS Recipients in Hospital: What You Need to Know
You may want to see also

BGM quality control
BGM, or Blood Glucose Monitoring, is a crucial process for individuals with diabetes to manage their blood sugar levels effectively. The use of BGM requires permanent quality control (QC) to ensure accurate results and avoid potential health consequences.
Quality control for BGM involves regularly checking the measurement quality of the device and performing internal QC according to the manufacturer's recommendations. However, a study in Poland found that only 42% of hospitals performed internal QC, and only one hospital conducted QC daily. There is a lack of policy regarding QC for BGM in many hospitals, which can lead to potential health risks for patients.
To ensure accurate and reliable results, BGM devices should be properly controlled and maintained. The current standards for QC of BG measurement in laboratories require testing at 2-3 levels of glucose concentrations, 2-3 times daily. While BGM devices are considered low-maintenance, weekly QC is generally acceptable.
Manufacturers of BGM devices provide control solutions (CSs) to check the accuracy of glucose measurements. However, there is no universal CS, and each manufacturer offers a specific CS for their BGM. The viscosity of CSs differs from capillary blood, impacting the measurement results. CSs are not interchangeable and are system-specific, even within the same manufacturer.
To improve the reliability of BGM devices, diabetes associations and manufacturers should establish unified recommendations for QC. Regular and proper control of BG has been shown to positively impact morbidity, mortality, and treatment costs. By defining clear guidelines for QC, hospitals can improve the accuracy of BGM devices and enhance patient outcomes.
Hospitals and Delivery: Shaving - An Outdated Practice?
You may want to see also

BGM in hospitals
BGM is a medical abbreviation with several meanings, two of which are commonly used in hospitals.
Blood Glucose Monitoring
Blood Glucose Monitoring (BGM) is a crucial process for individuals with diabetes to manage their blood sugar levels effectively. BGM can refer to the process of monitoring or the device used to monitor blood glucose levels. Personal blood glucose meters are used mainly by diabetic patients, but they are also frequently used in hospitals as point-of-care test (POCT) devices.
The use of BGM in hospitals requires permanent quality control (QC) to avoid the potential risk of severe health consequences if devices are not properly controlled. Most BGM manufacturers recommend performing QC upon the first use of the device, when a new box/vial of test strips is opened, and in the case of a suspected malfunction or inconsistent test results.
BioGenomics Medicine
BioGenomics Medicine (BGM) is an emerging field that combines genomics and medicine. It is mostly used in health and diabetes contexts.
Finding Lawsuits Against Hospitals: A Step-by-Step Guide
You may want to see also
Frequently asked questions
BGM stands for Blood Glucose Monitoring or Blood Glucose Meter.
Blood Glucose Monitoring is a crucial process for individuals with diabetes to manage their blood sugar levels effectively.
A Blood Glucose Meter is a device used for the determination of glucose mainly by diabetic patients.

















